FindTrial
Sign In

Role of Bcl-2 and Ki67 in endometrial lesions

Immunohistochemical expression of Bcl-2 and Ki-67 in non-neoplastic and neoplastic endometrial lesions- A cross sectional study - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/02/062918
Enrollment
60
Registered
2024-02-20
Start date
Unknown
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C541- Malignant neoplasm of endometrium

Interventions

Control Intervention1: Nil: Nil

Sponsors

Pragya chitravanshi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All histopathologically confirmed cases of non neoplastic and neoplastic endometrial lesions.

Exclusion criteria

Exclusion criteria: Patients who are on hormonal therapy Biopsies diagnosed as the product of conception Biopsies that are unsatisfactory

Design outcomes

Primary

MeasureTime frame
To classify non neoplastic and neoplastic endometrial lesions on the basis of histomorphology. To evaluate Bcl-2 and Ki-67 expression in non-neoplastic and neoplastic endometrial lesions. To correlate Bcl-2 with Ki-67 expression in these lesionsTimepoint: Monthly—

Secondary

MeasureTime frame
To classify non neoplastic & neoplastic endometrial lesions on the basis of histomorphology. To evaluate Bcl-2 & Ki-67 expression in non-neoplastic & neoplastic endometrial lesions. To correlate Bcl-2 with Ki-67 expression in these lesionsTimepoint: 4 weeks—

Countries

India

Contacts

Public ContactPragya chitravanshi

Rohilkhand Medical College and Hospital

anjanaarya.singh15@gmail.com9412125824

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026